Zheng Wei, Wang Pingli, Cao Zengzhen
Department of Thoracic and Cardiovascular Surgery, The Affiliated Yongchuan Hospital of Chongqing Medical University, No. 439, Xuanhua Road, Yongchuan District, Chongqing, 402160, China.
BMC Pulm Med. 2025 Aug 1;25(1):369. doi: 10.1186/s12890-025-03853-0.
This study evaluates the impact of a modified chest drainage tube on postoperative recovery and its clinical application value by comparing the drainage efficacy of the modified tube with conventional chest drainage tubes after uniportal video-assisted thoracoscopic surgery (VATS) for lung cancer.
A retrospective analysis of clinical data from 100 patients who underwent uniportal VATS radical surgery for lung cancer in the department of thoracic and cardiovascular surgery at our hospital between January 2023 and January 2024 was conducted. Of these, 50 patients received the modified chest drainage tube postoperatively (experimental group), while 50 patients received the conventional chest drainage tube (control group). Postoperative outcomes, including thoracic drainage volume, duration of chest tube placement, length of hospital stay, wound healing, pain levels, and tube reinsertion rates, were compared between the two groups.
The experimental group demonstrated significantly improved outcomes in terms of chest tube placement duration, length of hospital stay, wound healing, and pain levels compared to the control group, with statistically significant differences (P < 0.05). However, no statistically significant differences were observed between the two groups regarding postoperative thoracic drainage volume and tube reinsertion rates (P > 0.05).
The modified chest drainage tube used after uniportal VATS radical surgery for lung cancer exhibits safety and efficacy, facilitates rapid recovery, and demonstrates potential clinical value.
本研究通过比较改良胸腔引流管与传统胸腔引流管在单孔电视辅助胸腔镜手术（VATS）治疗肺癌后的引流效果，评估改良胸腔引流管对术后恢复的影响及其临床应用价值。
对2023年1月至2024年1月在我院胸心血管外科接受单孔VATS肺癌根治术的100例患者的临床资料进行回顾性分析。其中，50例患者术后接受改良胸腔引流管（实验组），50例患者接受传统胸腔引流管（对照组）。比较两组患者的术后结果，包括胸腔引流量、胸管留置时间、住院时间、伤口愈合情况、疼痛程度和胸管再次插入率。
与对照组相比，实验组在胸管留置时间、住院时间、伤口愈合和疼痛程度方面的结果有显著改善，差异有统计学意义（P < 0.05）。然而，两组在术后胸腔引流量和胸管再次插入率方面未观察到统计学显著差异（P > 0.05）。
单孔VATS肺癌根治术后使用的改良胸腔引流管具有安全性和有效性，有助于快速恢复，并显示出潜在的临床价值。
